| Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the … AC Kalil, ML Metersky, M Klompas, J Muscedere, DA Sweeney, ... Clinical infectious diseases 63 (5), e61-e111, 2016 | 4154 | 2016 |
| Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of … JP Metlay, GW Waterer, AC Long, A Anzueto, J Brozek, K Crothers, ... American journal of respiratory and critical care medicine 200 (7), e45-e67, 2019 | 3333 | 2019 |
| Community-acquired pneumonia requiring hospitalization among US adults S Jain, WH Self, RG Wunderink, S Fakhran, R Balk, AM Bramley, C Reed, ... New England Journal of Medicine 373 (5), 415-427, 2015 | 2540 | 2015 |
| Community-acquired pneumonia requiring hospitalization among US children S Jain, DJ Williams, SR Arnold, K Ampofo, AM Bramley, C Reed, ... New England Journal of Medicine 372 (9), 835-845, 2015 | 1898 | 2015 |
| SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia PGP Charles, R Wolfe, M Whitby, MJ Fine, AJ Fuller, R Stirling, AA Wright, ... Clinical infectious diseases 47 (3), 375-384, 2008 | 785 | 2008 |
| Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia GW Waterer, GW Somes, RG Wunderink Archives of internal medicine 161 (15), 1837-1842, 2001 | 563 | 2001 |
| Community-acquired pneumonia RG Wunderink, GW Waterer New England Journal of Medicine 370 (6), 543-551, 2014 | 406 | 2014 |
| Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects S Yende, GW Waterer, EA Tolley, AB Newman, DC Bauer, DR Taaffe, ... Thorax 61 (1), 10-16, 2006 | 386 | 2006 |
| Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations GW Waterer, MW Quasney, RM Cantor, RG Wunderink American journal of respiratory and critical care medicine 163 (7), 1599-1604, 2001 | 328 | 2001 |
| Hypercoagulation and antithrombotic treatment in coronavirus 2019: a new challenge F Violi, D Pastori, R Cangemi, P Pignatelli, L Loffredo Thrombosis and haemostasis 120 (06), 949-956, 2020 | 287 | 2020 |
| The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures GW Waterer, RG Wunderink Respiratory medicine 95 (1), 78-82, 2001 | 287 | 2001 |
| Procalcitonin as a marker of etiology in adults hospitalized with community-acquired pneumonia WH Self, RA Balk, CG Grijalva, DJ Williams, Y Zhu, EJ Anderson, ... Clinical Infectious Diseases 65 (2), 183-190, 2017 | 273 | 2017 |
| Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists YCG Lee, MH Baumann, NA Maskell, GW Waterer, TE Eaton, RJO Davies, ... Chest 124 (6), 2229-2238, 2003 | 272 | 2003 |
| The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy PGP Charles, M Whitby, AJ Fuller, R Stirling, AA Wright, TM Korman, ... Clinical Infectious Diseases 46 (10), 1513-1521, 2008 | 266 | 2008 |
| Severity of pneumococcal pneumonia associated with genomic bacterial load J Rello, T Lisboa, M Lujan, M Gallego, C Kee, I Kay, D Lopez, GW Waterer, ... Chest 136 (3), 832-840, 2009 | 246 | 2009 |
| Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia MI Restrepo, EM Mortensen, GW Waterer, RG Wunderink, JJ Coalson, ... European respiratory journal 33 (1), 153-159, 2008 | 234 | 2008 |
| Staphylococcus aureus Community-acquired Pneumonia: Prevalence, Clinical Characteristics, and Outcomes WH Self, RG Wunderink, DJ Williams, Y Zhu, EJ Anderson, RA Balk, ... Reviews of Infectious Diseases 63 (3), 300-309, 2016 | 223 | 2016 |
| Advances in the causes and management of community acquired pneumonia in adults RG Wunderink, G Waterer Bmj 358, 2017 | 221 | 2017 |
| The impact of estrogen and progesterone on asthma CL Haggerty, RB Ness, S Kelsey, GW Waterer Annals of Allergy, Asthma & Immunology 90 (3), 284-291, 2003 | 204 | 2003 |
| Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion ETH Fysh, GW Waterer, PA Kendall, PR Bremner, S Dina, E Geelhoed, ... Chest 142 (2), 394-400, 2012 | 203 | 2012 |
Y C Gary LeeProfessor of Respiratory Medicine, University of Western AustraliaVerified email at uwa.edu.au
